Mental Health Blogs

News is out that Lilly, makers of the antipsychotic Zyprexa, will pay $22.5 million to settle a lawsuit brought by the State of West Virginia which claimed that the company had illegally marketed the drug for unapproved uses including dementia

Lilly told Bloomberg:

“‘We think that putting the issue behind us is not only in the best interest of Lilly but in that of patients, caregivers and health care professionals,’ Marni Lemons, a Lilly spokeswoman, said today.”

Yes, Lilly always has patients’ best interests in mind.

Go to Source

Related posts:

1. Lilly Settles Zyprexa Claims With Idaho
2. Lilly Settles South Carolina Zyprexa Claims For $45 Million
3. Lilly Settles Zyprexa Claims With Another 7 States
4. Lilly Settles Zyprexa Claims With South Carolina
5. Lilly Settles Mississippi Zyprexa Claims For $18.5 Million